Van S. Tompkins

1.5k total citations
35 papers, 1.1k citations indexed

About

Van S. Tompkins is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Van S. Tompkins has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Van S. Tompkins's work include Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (9 papers) and RNA and protein synthesis mechanisms (7 papers). Van S. Tompkins is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (9 papers) and RNA and protein synthesis mechanisms (7 papers). Van S. Tompkins collaborates with scholars based in United States, China and Germany. Van S. Tompkins's co-authors include Dawn E. Quelle, Jussara Hagen, Chandrashekhar K. Korgaonkar, Siegfried Janz, April A. Frazier, Frederick W. Quelle, Chantal Allamargot, Walter N. Moss, Seong‐Su Han and Stefan Rose‐John and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Van S. Tompkins

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Van S. Tompkins United States 18 724 481 160 129 118 35 1.1k
Lucia Mazzacurati United States 14 550 0.8× 387 0.8× 120 0.8× 74 0.6× 88 0.7× 22 956
Mayuko Omori United States 10 883 1.2× 294 0.6× 122 0.8× 56 0.4× 74 0.6× 14 1.2k
Frédéric Zilbermann Switzerland 7 896 1.2× 228 0.5× 122 0.8× 72 0.6× 93 0.8× 8 1.1k
Jayakumar R. Nair United States 18 672 0.9× 540 1.1× 115 0.7× 208 1.6× 97 0.8× 45 1.3k
Marco Cirò Italy 10 859 1.2× 320 0.7× 225 1.4× 77 0.6× 35 0.3× 11 1.1k
Suhu Liu United States 18 946 1.3× 476 1.0× 333 2.1× 94 0.7× 76 0.6× 34 1.4k
Carmela De Marco Italy 20 691 1.0× 336 0.7× 242 1.5× 39 0.3× 113 1.0× 34 1000
Haiyun Cheng United States 9 568 0.8× 472 1.0× 193 1.2× 73 0.6× 111 0.9× 12 944
Vanessa Baeriswyl Switzerland 12 728 1.0× 452 0.9× 190 1.2× 52 0.4× 52 0.4× 14 1.1k

Countries citing papers authored by Van S. Tompkins

Since Specialization
Citations

This map shows the geographic impact of Van S. Tompkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Van S. Tompkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Van S. Tompkins more than expected).

Fields of papers citing papers by Van S. Tompkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Van S. Tompkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Van S. Tompkins. The network helps show where Van S. Tompkins may publish in the future.

Co-authorship network of co-authors of Van S. Tompkins

This figure shows the co-authorship network connecting the top 25 collaborators of Van S. Tompkins. A scholar is included among the top collaborators of Van S. Tompkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Van S. Tompkins. Van S. Tompkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tompkins, Van S., et al.. (2024). The RNA secondary structure of androgen receptor-FL and V7 transcripts reveals novel regulatory regions. Nucleic Acids Research. 52(11). 6596–6613. 1 indexed citations
2.
Tompkins, Van S., et al.. (2024). Identification of MYC intron 2 regions that modulate expression. PLoS ONE. 19(1). e0296889–e0296889.
3.
Peterson, Jake M., et al.. (2023). Discovery of RNA secondary structural motifs using sequence-ordered thermodynamic stability and comparative sequence analysis. MethodsX. 11. 102275–102275. 1 indexed citations
4.
Tompkins, Van S., et al.. (2022). Analyses of human cancer driver genes uncovers evolutionarily conserved RNA structural elements involved in posttranscriptional control. PLoS ONE. 17(2). e0264025–e0264025. 6 indexed citations
5.
Andrews, Ryan J., Collin A. O’Leary, Van S. Tompkins, et al.. (2021). A map of the SARS-CoV-2 RNA structurome. NAR Genomics and Bioinformatics. 3(2). lqab043–lqab043. 44 indexed citations
6.
Tompkins, Van S., et al.. (2020). Differential expression analysis comparing EBV uninfected to infected human cell lines identifies induced non-micro small non-coding RNAs. Non-coding RNA Research. 5(1). 32–36. 3 indexed citations
7.
Holman, Carol, Van S. Tompkins, Xuefang Jing, et al.. (2016). KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice. Blood Cancer Journal. 6(2). e398–e398. 15 indexed citations
8.
Han, Seong‐Su, Van S. Tompkins, Sang Woo Han, et al.. (2015). CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma. Experimental Hematology and Oncology. 4(1). 9–9. 10 indexed citations
9.
Reed, Sara M., Jussara Hagen, Nicholas Borcherding, et al.. (2014). NIAM-Deficient Mice Are Predisposed to the Development of Proliferative Lesions including B-Cell Lymphomas. PLoS ONE. 9(11). e112126–e112126. 5 indexed citations
10.
Gao, Minjie, Guang Yang, Van S. Tompkins, et al.. (2014). Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials. PLoS ONE. 9(10). e109758–e109758. 4 indexed citations
11.
Gao, Minjie, Lu Gao, Tao Yi, et al.. (2014). Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells. Acta Biochimica et Biophysica Sinica. 46(6). 484–491. 13 indexed citations
12.
Han, Seong‐Su, Van S. Tompkins, Dong Ju Son, et al.. (2013). Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells. Biochemical and Biophysical Research Communications. 436(4). 660–665. 22 indexed citations
13.
Hagen, Jussara, Gary S. Coombs, Christine M. Eischen, et al.. (2013). RABL6A, a Novel RAB-Like Protein, Controls Centrosome Amplification and Chromosome Instability in Primary Fibroblasts. PLoS ONE. 8(11). e80228–e80228. 10 indexed citations
14.
Tompkins, Van S., Alicia K. Olivier, Ramakrishna Sompallae, et al.. (2013). 18F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib. Blood Cancer Journal. 3(11). e165–e165. 22 indexed citations
15.
Han, Seong‐Su, Van S. Tompkins, Liangping Peng, et al.. (2010). NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma. Molecular Cancer. 9(1). 97–97. 105 indexed citations
16.
Tommaso, Anne Di, Jussara Hagen, Van S. Tompkins, et al.. (2009). Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities. Experimental Cell Research. 315(7). 1326–1335. 18 indexed citations
17.
Hagen, Jussara, Van S. Tompkins, Amel Dudakovic, Jamie A. Weydert, & Dawn E. Quelle. (2008). Generation and Characterization of Monoclonal Antibodies to NIAM: A Nuclear Interactor of ARF and Mdm2. Hybridoma. 27(3). 159–166. 4 indexed citations
18.
Tanida, Satoshi, et al.. (2008). Adenovirus E1A oncoprotein liberates c‐Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1‐dependent mechanism. Journal of Cellular Physiology. 216(3). 621–631. 20 indexed citations
19.
Tompkins, Van S., Jussara Hagen, April A. Frazier, et al.. (2006). A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability. Journal of Biological Chemistry. 282(2). 1322–1333. 32 indexed citations
20.
Korgaonkar, Chandrashekhar K., Jussara Hagen, Van S. Tompkins, et al.. (2005). Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function. Molecular and Cellular Biology. 25(4). 1258–1271. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Mazzacurati Breakdown of academic impact, for papers by Mayuko Omori Breakdown of academic impact, for papers by Frédéric Zilbermann Breakdown of academic impact, for papers by Jayakumar R. Nair Breakdown of academic impact, for papers by Marco Cirò Breakdown of academic impact, for papers by Suhu Liu Breakdown of academic impact, for papers by Carmela De Marco Breakdown of academic impact, for papers by Haiyun Cheng Breakdown of academic impact, for papers by Vanessa Baeriswyl
Rankless by CCL
2026